3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
5
Rhabdoid Tumor
5
Osteosarcoma
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Glioma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Central Nervous System Neoplasms
4
Sarcoma, Ewing
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroendocrine Tumors
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Xanthogranuloma, Juvenile
1
Thyroid Cancer, Papillary
1
Non functioning pancreatic endocrine tumor
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Lymphoma
1
Histiocytic Sarcoma
1
Familial ependymoma
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
20
enzalutamide
19
apalutamide
17
Prednisone
13
Androgen Antagonists
13
Abiraterone Acetate
13
Specimen Handling
12
abiraterone
8
Radiotherapy
8
Docetaxel
8
Biopsy
8
darolutamide
7
Nivolumab
7
cabazitaxel
6
Radiosurgery
6
Pluvicto
6
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
6
Lutetium-177
5
radium Ra 223 dichloride
4
gallium 68 PSMA-11
4
cabozantinib
4
bicalutamide
4
atezolizumab
4
Surveys and Questionnaires
4
Standard of Care
4
Radiotherapy, Intensity-Modulated
4
Radiation
4
Lutetium
4
pembrolizumab
3
olaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Phantoms, Imaging
×
30 days
×
Clear all
No trials found.